16

It is a 19-item questionnaire that is designed to evaluate three

primary areas: teamwork and collaboration, professional identity, and roles and

responsibilities. The Interdisciplinary Education Perception Scale (IEPS) is another

tool that assesses attitudes toward IPE.

17 This scale is an 18-item questionnaire that

contains 4 subscale measures: competency and autonomy, perceived need for

cooperation, actual cooperation, and understanding the value of others. Assessment

instruments such as RIPLS and IEPS have been used to measure the impact that IPE

experiences may have on students’ pre-exposure acceptance and attitudes. Although

these and some other tools may be useful for measuring change in behavior or

attitudes concerning IPE, they do not assess the impact that IPE may have on patient

outcomes.

2

IPE MODELS

The creation of an effective model for IPE should start with the understanding that

this is just the initial step in providing patient directed care.

2 An interprofessional

environment helps students from one profession learning from individuals

representing another discipline to better develop skills that will help improve their

own professional specific skills and to more effectively work in team-based setting.

2

It is important that all representatives of a particular profession, including students

and practitioners, be socialized to their own profession as well as to the

interdisciplinary setting. There also needs to be a commitment that IPE be

incorporated within the curricula of all programs within an institution to help sustain

its viability for the future.

2

In addition to other health profession students, pharmacy students should be

considered essential to any IPE model. Pharmacists have not always been considered

necessary on a healthcare team, and this needs to be addressed when developing IPE

teams.

2

IPE teams should ideally include a pharmacy student, in addition to medicine,

nursing, social work, and nutrition students.

2

The stage of socialization within the specific profession must be considered when

creating teams as well.

2 Socialization of healthcare students has been defined as “the

acquisition of knowledge, skills, values, roles and attitudes of associated with the

practice of that particular profession,” and can be exhibited by the language,

behavior, and demeanor that are representative of that specific discipline.

2

It is

important that a student maintains his/her professional identity when participating in

an IPE models. Also when creating student teams, one should try balance them with

regard to what point they are in their professional socialization and education.

2 A

medical student who is in the 4th year of his/her program who is paired with less

experienced nursing or pharmacy student may negatively impact learning of the other

students if the medical student assumes a more dominant role.

2

CASE 7-5

QUESTION 1: M.M. is a 65-year-old retired man who presented to his provider three days ago with

complaints of increasing shortness of breath (dyspnea) upon exertion. He reports noting swelling in his ankles

for months that has started to get worse over the past 2 weeks, making it difficult to wear his shoes on toward

the end of the day and going up the stairs to his apartment. In the past week, he has had a decreased appetite,

some nausea and vomiting, and tenderness in the right upper quadrant of the abdomen. He reports that he has

not taken his medications in the past month because he didn’t think they were helping him. The patient lives

alone with his dog in a small two-bedroom apartment on the second floor of a multifamily home. He has a

daughter who lives in another state and who visits him during the holidays. The patient was hospitalized and

treated for a diagnosis of exacerbation of CHF and is now being discharged home. A physician, nurse, social

worker, and pharmacist are part of a discharge planning team working with M.M. How does the approach of

the pharmacist to M.M.’s care differ from that of the other team members?

One element of an IPE model is understanding that different professions may vary

in how they approach patient care. Medicine and pharmacy tend to focus on

eliminating or “ruling-out” causes of a patient’s complaint, whether it is medical- or

drug-related.

2 While the physician will focus primarily on the medical evaluation of

M.M., the pharmacist would determine whether any of his medications were causing

any effects which may have contributed to his belief that they were not helping him.

The pharmacist would also work with M.M. to develop a plan that would enhance

adherence to his discharge medications. Some other members of the team, such as the

nurse and social worker, may take a more holistic approach and address the patient

from a broader perspective.

2 This would include considering any family or

environment issues that may affect M.M.’s progress such as ability for self-care when

living alone and not having a relative living close by. They could make arrangements

to make sure M.M. has the proper support at home. The nurse can also educate the

patient about the importance of adherence to proper diet and to recognize early signs

and symptoms of exacerbation. Some professions such as social work or psychology

tend to be more involved with the patient or family for a more prolonged period of

time, particularly if change in behavior is warranted.

2 Another consideration with

how different professions approach patient care is that medical students are typically

trained to be decision-makers regarding clinical problem-solving, which has been a

long-standing part of the culture of medicine.

18 As noted previously, team-based care

means a shared responsibility for patient care on the part of all team members and

should not be dominated by any one profession.

CASE 7-6

QUESTION 1: Your university has an IPE day where medical students, nursing students, pharmacy students,

and physician assistant students work in teams on simulated patient cases using a manikin. Is this considered an

appropriate strategy for delivering IPE?

It is important to understand that IPE models can take place in a variety of settings,

such a classroom, laboratory, and a patient care setting. Regardless of the

environment, IPE-related activities should represent a “real-world” experience.

2

Simulation activities (simulating a patient care setting) and case discussions in a

seminar format, where participants can exchange information, are appropriate for the

early professional education years. Students may also observe activities of health

providers upon patient visits and reflect on the contributions of each to patient care.

The patient care setting is more appropriate for students with more experience.

2

In

addition to certainly being real world, it is more effective in developing the

confidence and skills needed for students to function as part of the team. In this

experiential setting, clinicians from multiple professions who are active and engaged

as role models and mentors are critical to the success of the model.

2

Bridges and colleagues describe three different practice models of IPE,

representing a didactic program, a community-based experience, and an

interprofessional simulation experience.

19 The didactic program focuses on

developing interprofessional team building skills, understanding other professions,

and how culture

p. 97

p. 98

influences healthcare delivery. Students work in small groups and also engage in a

community service project. There is also a clinical component where students from

different professions form teams and attend a prescribed number of sessions at a

practice site. The community model illustrates how collaboration by different

professions can provide patient care services to many underserved individuals in

their homes. Teams of students are assigned home visits in a manner so that they are

exposed to a variety of family types (e.g., Medicaid family with multiple children,

older adult living alone, hospice patient). Each team has a project that they present to

their group at the end of the course. With the simulation model, students from

different professions use simulation and not real patients to promote interprofessional

teamwork. Even though there are a number of different strategies that may be used to

deliver IPE, the common elements that lead to more successful experience include

responsibility, assertiveness, accountability, coordination, communication, trust,

respect autonomy, and cooperation.

19

POTENTIAL BARRIERS TO IPE

CASE 7-7

QUESTION 1: Although IPE is considered important, are there any barriers to implementing it?

Despite the progress made in advancing IPE over the past few years, some

barriers to implementing it exist on different levels, from the institution/organization

level down to the individual level. Overcoming these barriers is important in order

to continue to work toward preparing students to collaborate with other healthcare

professionals.

On the institutional/organizational level, academic calendars and requirements

may differ between various healthcare disciplines. Also the requirements for

assessing students may differ between professions due to accrediting body standards,

and the timing of when topics are covered within the degree program may not be

consistent. Finding a common time for students to meet is often a challenge, and there

may not be available classroom space available to accommodate the increased

number of students. In addition, the curricula of the different professions may also

provide little flexibility in terms of incorporating IPE into the curriculum, although

mandates by accrediting bodies such as ACPE dictate that this needs to happen for

some professions. There may not be an adequate number of faculties trained in the

area of IPE, and there may be insufficient faculty development efforts to address this

issue. Collaboration with IPE efforts also may be negatively affected by geographic

separation between disciplines that may exist within the institution.

2,20

It is important

that the institution’s administration commits the necessary financial and other

resources necessary to address some of these potential obstacles to IPE.

There may also be barriers to IPE at the individual level. Differences in attitudes

that exist between heath care professions can impact the implementation of IPE. It has

been shown that healthcare providers may have negative opinions of each other’s

clinical knowledge and ability.

21 Michalec and colleagues surveyed over 600 firstyear students from 6 different professions, including pharmacy, assessing their

perceptions and stereotypes of their own as well as other healthcare professions.

21

The students rated the six professions based on nine distinct positive attributes

(academic ability, professional competence, interpersonal skills, leadership ability,

ability to work independently, ability to be a team player, ability to make decisions,

practical skills, and confidence). Although medicine rated highest for most of these

attributes, they rated lowest for ability to be a team player, which is contrary to the

mission of team-based health care. Compared to the other professions (nursing,

occupational therapy, physical therapy, couple and family therapy), pharmacy and

medicine also scored low on interpersonal skills, which is a negative when it comes

to working with others. Granted these are only perceptions of students about other

health professions before any interaction, but they may represent potential barriers to

providing team-based patient care.

Faculty also need to understand the value of IPE so they can be actively involved

in implementing any program at their institution. Faculty may resist IPE if it results in

an increase in workload and causes time constraints.

1

FUTURE OF IPE

The first challenge is to sustain the IPE momentum that has been developed over the

past several years and to provide the necessary resources to support it.

22 Expansion

of IPE is also been identified as a future goal.

23 Further opportunities for

collaboration between professions need to be identified, and the education of

healthcare students needs to advance to the point where team-based learning is the

norm, and that improved patient care is achieved.

23

It is believed that in the future,

students and faculty will have multiple opportunities to interact with others, and that

these experiences will further commit them to work together to improve patient

outcomes.

There are still a number of issues concerning IPE that need to be addressed. There

needs to be more objective evidence on the impact of IPE on improving patient

outcomes.

24

In addition, there are still questions concerning how much IPE is needed

to achieve learner competence, where in the curriculum does IPE have the greatest

impact and what are the most effective formats for delivering IPE.

24

1.

2.

3.

4.

5.

6.

CONCLUSION

The traditional model of practitioners working alone to provide patient care can

result in communication failures and is detrimental to patient safety. A care plan that

utilizes teams of healthcare providers, including pharmacists, to coordinate patient

care can optimize patient outcomes. IPE can lead to better understanding of the roles

and responsibilities of team members, improved communication and more effective

teamwork.

8 Table 7-1 summarizes some suggested criteria for an organization to be

engaged toward IPE.

Table 7-1

Suggested Criteria for Engagement for Interprofessional Education

A well-known, observable, measurable IPE philosophy that permeates the organization.

Faculty from different healthcare professions working together to develop the learning experiences.

Students having integrated didactic and experiential opportunities to learn how to build teams and to

collaborate, and how working together can improve patient care.

IPE learning experiences being incorporated into to the curricula as a requirement.

Competence demonstrated by students with a defined set of competencies such as those outlined by the

Interprofessional Education Collaboration.

Organization infrastructure that fosters and supports IPE including faculty time to develop IPE and having

collaborative activities across the various professions.

Adapted from Barnsteiner JH. Promoting interprofessional education. Nurs Outlook. 2007;55:144–150.

p. 98

p. 99

KEY REFERENCES AND WEBSITES

A full list of references for this chapter can be found at

http://thepoint.lww.com/AT11e. Below are the key references and websites for this

chapter, with the corresponding reference number in this chapter found in parentheses

after the reference.

Key References

Buring SM et al. Interprofessional education: definitions, student competencies, and guidelines for implementation.

Am J Pharm Educ. 2009;73(4):59. (1)

American College of Clinical Pharmacy. Interprofessional education: principles and application. A framework for

pharmacy. Pharmacotherapy. 2009;29(3):145e–164e. (2)

Key Websites

Interprofessional Education Collaboration. http://www.aacn.nche.edu/education-resources/ipecreport.pdf

Centre for the Advancement of Interprofessional Education. http://caipe.org.uk/resources/defining-ipe/

COMPLETE REFERENCES CHAPTER 7

INTERPROFESSIONAL EDUCATION AND PRACTICE

Buring SM et al. Interprofessional education: definitions, student competencies, and guidelines for implementation.

Am J Pharm Educ. 2009;73(4):59.

American College of Clinical Pharmacy. Interprofessional education: principles and application. A framework for

pharmacy. Pharmacotherapy. 2009;29(3):145e–164e.

Institute of Medicine. Educating for the Health Team. Washington, DC: National Academy of Sciences; 1972.

Greiner A, ed. Institute of Medicine Report. Health Professions Education a Bridge: To Quality. Washington, DC:

National Academies Press, 2003.

Interprofessional Education Collaboration. Core competencies for interprofessional collaborative practice. Report

of an expert panel. 2011. Available at: https://ipecollaborative.org/uploads/IPEC-CoreCompetencies.pdf. Accessed August 30, 2016.

Core competencies for interprofessional collaborative practice. 2016 Update. Available at:

https://www.ipecollaborative.org/uploads/IPEC-2016-Updated-Core-CompetenciesReport__final_release_.PDF. Accessed February 20, 2017.

Rittenhouse DR, Shortell SM. The patient-centered medical home. Will it stand the test of health reform? JAMA.

2009;301:2038–2040.

Bressler T, Persico L. Interprofessional education: partnerships in the educational proc. Nurs Educ Pract. 2016:16

(1); 144–147.

Dacey M et al. An interprofessional service- learning course: uniting students across educational levels and

promoting patient-centered care. J Nurs Educ. 2010;49:696–699.

Lapkin S et al. A systematic review of interprofessional education in health professional programs. Nurse Educ

Today. 2013;33:90–102.

Brock T et al. Health care education must be more of a team sport. Am J Pharm Educ. 2016;80(1):1.

Centre for the Advancement of Interprofessional Education. Defining IPE 2002.

http://caipe.org.uk/resources/defining-ipe/. Accessed August 25, 2016

Cooper H et al. Beginning the process of teamwork: design, implementation and evaluation of an interprofessional education intervention for first year undergraduate students. J Interprofessional Care. 2005;19:492–

508.

Tunstall-Pedoe S et al. Students attitudes to understanding interprofessional education. J Interprofessional Care.

2003;17:161–172.

Accreditation Council for Pharmacy Education. Accreditation standards and key elements for the professional

program in pharmacy leading to the doctor of pharmacy degree. “Standards 2016”. 2016. Available at:

https://www.acpe-accredit.org/standards. Accessed August 28, 2016.

Parsell G, Bligh J. The development of a questionnaire to assess the readiness of health care students for

interprofessional learning (RIPLS). Med Educ. 1999;33:95–100.

Lueccht RM et al. Assessing professional perceptions: design and validation of an Interdisciplinary Education

Perception Scale. J Allied Health. 1990;19:181–191.

Leape LL, Berwick DM. Five years after to err is human: what have we learned? JAMA. 2005;293:2384–2390.

Bridges DR et al. Interprofessional collaboration: three best practice models of interprofessional education. Med

Educ Online. 2011;16:60350. doi:10:3402/meo.v16i0.6035.

Lawlis TR et al. Barriers and enablers that influence sustainable interprofessional education: a literature review. J

Interprofessional Care. 2014;28:305–310.

Michalec B et al. Dissecting first-year students’ perceptions of health profession groups. Potential barriers to

interprofessional education. J Allied Health. 2013;42:202–213.

Schmitt MH et al. The coming of age for interprofessional education and practice. Am J Med. 2013;126:284–288.

Graybeal C et al. The art and science of interprofessional education. J Allied Health. 2010;39:232–237.

Nickol DR. Interprofessional education: what’s now, and what’s next. J Interprofessional Educ Pract. 2015;1:1–

2.

p. 99

The risk of atherosclerosis is directly related to increasing levels of

serum cholesterol. Cholesterol, specifically lipoproteins, plays a central

role in the pathogenesis of atherosclerosis. Thus, low-density lipoprotein

cholesterol (LDL-C) is the primary target for intervention. The

American College of Cardiology/American Heart Association

(ACC/AHA) guideline and the National Lipid Association (NLA)

recommend management for patients at high risk. This includes patients

with atherosclerotic cardiovascular disease (ASCVD) as well as those

with familial hypercholesterolemia (FH).

Case 8-1 (Question 1)

Every patient with dyslipidemia should be evaluated for secondary

causes of elevated LDL-C, non–HDL-C, or triglycerides (TGs). These

causes may be related to concomitant medications or due to a clinical

condition.

Case 8-1 (Questions 2, 3),

Table 8-5

LDL-C goals and the thresholds for instituting therapeutic lifestyle

changes (TLC) and pharmacotherapy are guided by the presence of

clinical atherosclerosis or based on cardiovascular risk.

Case 8-2 (Questions 1, 2),

Case 8-3 (Question 1),

Case 8-4 (Questions 1, 2)

An adequate trial of TLC should be used in all patients, but

pharmacotherapy should be instituted concurrently in high-risk patients

and patients should be monitored for adverse effects.

Case 8-2 (Question 2),

Case 8-5 (Question 1)

In most cases, statins are the medications of choice to treat high LDL-C

because of their ability to substantially reduce LDL-C, ability to reduce

morbidity and mortality from atherosclerotic disease, convenient oncedaily dosing, and low risk of side effects. Management of these adverse

effects is necessary in order to optimize benefit.

Case 8-2 (Question 3)

Statins are the agents of choice to reduce LDL-C with low risk of

adverse effects. However, drug interaction knowledge is needed in

order to optimize efficacy without compromising safety.

Case 8-4 (Question 3)

Patients with high TGs are at increased risk of acute pancreatitis. The

primary goal in these individuals is to lower their TG levels with diet,

exercise, weight reduction, and TG-lowering drugs such as nicotinic

acid, fibrates, and omega-3 fatty acids.

Case 8-5 (Question 2),

Case 8-6 (Question 1)

Combination drug therapy is often needed in patients with severe lipid

abnormalities, higher risk individuals with lower LDL-C goals, or

patients with multiple lipid abnormalities such as those with the

metabolic syndrome who have a secondary target of non–HDL-C.

Case 8-6 (Question 2)

p. 100

p. 101

Dyslipidemias (one or more abnormalities of blood lipids) play an important

etiologic role in the pathogenesis of ASCVD, including coronary heart disease

(CHD), cerebrovascular disease, and peripheral arterial disease.

1 Successful

lifestyle changes and pharmacologic management of dyslipidemias have been shown

to reduce the risk of ASCVD events such as heart attack and stroke.

2–4 For

cardiovascular disease prevention, the clinician estimates the individual patient’s

ASCVD risk with available risk assessment tools, determines the intensity of lipidmodulating therapy to match the patient’s level of risk, and implements appropriate

treatments to meet and maintain treatment goals.

5–8

LIPID METABOLISM

Knowledge of lipid and lipoprotein metabolism is essential to understanding

therapeutic targets for pharmacologic agents. Lipids are small molecules that function

in the body’s storage of energy, in cellular signaling, and as components of cell

membranes. Cholesterol, an essential lipid, is the precursor molecule for the

formation of bile acids (which are required for absorption of nutrients), the synthesis

of steroid hormones (which provide important modulating effects in the body), and

the formation and integrity of cellular membranes. However, excess cholesterol plays

a central role in atherogenesis and subsequent atherothrombotic complications.

Cells derive cholesterol in two ways: by intracellular synthesis or by uptake from

the systemic circulation. Within each cell, cholesterol is synthesized through a series

of biochemical steps, many of which are catalyzed by enzymes (Fig. 8-1). The

irreversible and rate-limiting step in cholesterol production is the conversion of βhydroxyl-β-methylglutaryl coenzyme A (HMG-CoA) to mevalonic acid, which is

catalyzed by HMG-CoA reductase. One of the most effective lipid-lowering

therapies developed to date for managing dyslipidemias, HMG-CoA reductase

inhibitors or statins, competitively interferes with the binding of substrate to this

critical enzyme, thereby reducing the cellular synthesis of cholesterol. The

biosynthesis of cholesterol in humans follows a circadian rhythm with maximum

cholesterol synthesis occurring near midnight and minimum synthesis at midday.

9

Free cholesterol is esterified to cholesteryl esters for intracellular storage by the

action of the enzyme acetyl CoA acetyl transferase (ACAT). Two forms of ACAT

have been identified. ACAT1 is present in many tissues, including inflammatory

cells, whereas ACAT2 is present in intestinal mucosa cells and hepatocytes. ACAT2

is required for the esterification and absorption of dietary cholesterol from the gut. In

theory, inhibition of this enzyme could reduce the absorption of dietary cholesterol,

the secretion of cholesterol by the liver, and even the uptake and storage of

circulating cholesterol in inflammatory cells in the arterial wall. Several inhibitors of

ACAT have been developed; however, in clinical trials they did not appear to reduce

atherosclerosis and were possibly pro-atherogenic.

10

It is unlikely that there will be

any further development of this class of drugs for cardiovascular prevention.

TGs are lipids that serve as an important source of stored energy in adipose tissue.

TGs are synthesized from three molecules of fatty acids esterified to a glycerol

backbone. Phospholipids (PLs) are a class of lipids formed from fatty acids, a

negatively charged phosphate group, nitrogen-containing alcohol, and a glycerol

backbone. PLs are essential for cellular function and the absorption, storage, and

transport of lipids in the circulation. They form the monolayer on the surface of

lipoproteins which function to transport neutral lipids throughout the body. PLs are

amphipathic with a hydrophilic head and hydrophobic tail and form a membrane

bilayer of lipoproteins to deliver hydrophobic cargo (cholesterol and energy in the

form of fat) to other organs. PLs are also secreted into bile to aid in the digestion and

absorption of dietary fat and lipid-soluble nutrients from the diet. They stabilize

proteins within the membrane, function as cofactors in enzymatic reactions, and

participate in the oxidation of lipoproteins in the arterial wall (Fig. 8-2).

Figure 8-1 Biosynthetic pathway of cholesterol. *The rate limiting step in cholesterol biosynthesis. ApoB,

apolipoprotein B; Coenzyme A, Ubiquinone 10; IDL, intermediate density lipoprotein; LDL-C, low density

lipoprotein cholesterol.

p. 101

p. 102

Figure 8-2 Chemicalstructure of lipids. At the top is cholesterol, followed by oleic acid. In the middle is a

triglyceride comprised of an oleoyl, stearoyl, and palmitoyl chain attached to a glycerin backbone. At the bottom is

a phospholipid.

Lipoproteins

Cells also obtain cholesterol by extracting it from the systemic circulation. The

source of this cholesterol is the liver, where it is synthesized and secreted into the

systemic circulation. As discussed above, cholesterol and other fatty substances are

insoluble in water. Therefore, cholesterol, TGs, and PLs are packaged into watersoluble complexes called lipoproteins in the hepatocyte and enterocytes before being

secreted into the aqueous medium of the blood. These lipoproteins contain an oily

inner lipid core made up of cholesteryl esters and TGs and an outer hydrophilic coat

made up of PLs and unesterified cholesterol (Fig. 8-3). The outer coat also contains

at least one of a number of proteins known as “apoproteins,” which provide the

ligand for interaction with receptors on cell surfaces, act as cofactors for various

enzymes, and add structural integrity.

The three major lipoproteins found in the blood of fasting (10–12 hours) patients

are very low density lipoprotein (VLDL), low-density lipoprotein (LDL), and highdensity lipoprotein (HDL).

11 These particles vary in size, cholesterol and TG

composition, and accompanying proteins (Table 8-1 and Fig. 8-4).

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more